Coherus Oncology (CHRS) Net Margin Growth (3y) (2016 - 2026)
Coherus Oncology (CHRS) Net Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Coherus Oncology | 195.05 Mn | 28.00 Mn | 8.50 Mn | 22,216.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,216.00 |
| Dec 31, 2025 | 19,808.00 |
| Sep 30, 2025 | 26,842.00 |
| Jun 30, 2025 | 342,479.00 |
| Mar 31, 2025 | 3,915.00 |
| Dec 31, 2024 | 276.00 |
| Sep 30, 2024 | 65,556.00 |
| Jun 30, 2024 | 44,136.00 |
| Mar 31, 2024 | 761,344.00 |
| Dec 31, 2023 | -9,582.00 |
| Sep 30, 2023 | -7,879.00 |
| Jun 30, 2023 | -11,907.00 |
| Mar 31, 2023 | -26,409.00 |
| Dec 31, 2022 | -16,151.00 |
| Sep 30, 2022 | -23,508.00 |
| Jun 30, 2022 | -11,162.00 |
| Mar 31, 2022 | -10,591.00 |
| Jun 30, 2020 | 486,306.00 |
| Mar 31, 2020 | 5.17 Mn |
| Dec 31, 2019 | 901,618.00 |